Literature DB >> 12022534

Long-term results of aortic valve regurgitation after repair of ruptured sinus of valsalva aneurysm.

Toshifumi Murashita1, Takehiro Kubota, Yasuhiro Kamikubo, Norihiko Shiiya, Keishu Yasuda.   

Abstract

BACKGROUND: We reviewed our 35-year-experience to investigate the determinants of long-term results of aortic valve regurgitation (AR) after surgical repair of ruptured sinus of Valsalva aneurysms (RSVA).
METHODS: Between 1963 and 1998, a total of 35 patients aged 7 to 64 years underwent surgery for RSVA. The aneurysms ruptured into the right ventricle (n = 24), right atrium (n = 10), and left atrium (n = 1). In all, 19 patients had VSD and 9 patients had AR. A combined approach through aortotomy and the involved chamber was used for 24 patients. Either direct (n = 19) or patch (n = 16) closure was used to close the rupture hole. The AR was graded on a scale of 0 to IV by angiographic or echographic evaluation.
RESULTS: There were no early deaths. Late death occurred in 1 patient, whose AR deteriorated to grade III 20 years later. Two patients (5.7%) required reoperations on the aortic valve, because grade III AR was noted 8 and 26 years after operation, respectively. Freedom from postoperative grade III AR or higher was 93% at 10 years and was 87% at 20 years. Late AR was associated with preoperative and early postoperative AR (p < 0.05) but not with the presence of VSD, location of the fistula, surgical approach, or type of repair (direct vs patch). Multivariate analysis indicated that early postoperative AR was the only independent variable.
CONCLUSIONS: Late AR necessitating reoperation still confers significant risk in the long-term follow-up after repair of RSVA. No particular risk factor of preoperative conditions and surgical methods was elucidated in this study, and postoperative AR at discharge from the hospital was the only factor determining the long-term results of AR.

Entities:  

Mesh:

Year:  2002        PMID: 12022534     DOI: 10.1016/s0003-4975(02)03493-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Aortic sinus aneurysm and associated defects: can we extrapolate a morphogenetic theory from pathologic findings?

Authors:  Paolo Angelini
Journal:  Tex Heart Inst J       Date:  2005

2.  Unconventional uses of septal occluder devices: Our experience reviewed.

Authors:  Neeraj Awasthy; Munesh Tomar; S Radhakrishnan; Savitri Shrivastava
Journal:  Indian Heart J       Date:  2015-05-14

Review 3.  Ruptured Sinus of Valsalva Aneurysm and Gerbode Defects: Patient and Procedural Selection: the Key to Optimising Outcomes.

Authors:  Colm R Breatnach; Kevin P Walsh
Journal:  Curr Cardiol Rep       Date:  2018-08-20       Impact factor: 2.931

4.  Ruptured sinus of Valsalva aneurysm: Yet another hole to plug!

Authors:  Prafulla G Kerkar
Journal:  Ann Pediatr Cardiol       Date:  2009-01

5.  Surgical correction of ruptured aneurysms of the sinus of Valsalva using on-pump beating-heart technique.

Authors:  Ansheng Mo; Hui Lin
Journal:  J Cardiothorac Surg       Date:  2010-05-14       Impact factor: 1.637

6.  Incidental Finding of an Aorto-Right Atrial Fistula in a Patient Undergoing Repair of a Sinus of Valsalva Aneurysm.

Authors:  Byron R Rosero-Britton; Anthony Nguyen; Ibrahim Warsame; Muhammad Shabsigh; Luke Dong; James Wolfe; Bryan Whitson; Michael Essandoh
Journal:  Front Med (Lausanne)       Date:  2017-06-30

7.  Ruptured sinus of Valsalva aneurysms - our surgical experience of 7 years.

Authors:  Abhishek Shrinivas Joshi; Balaji Dattatray Aironi; Ninad Sunil Kotkar; Dwarkanath Vivekanand Kulkarni; Uday Eknath Jadhav; Ketak Mahendra Nagare
Journal:  Kardiochir Torakochirurgia Pol       Date:  2021-07-05

8.  Rupture of sinus of valsalva - A 15 years single institutional retrospective review: Preoperative heart failure has an impact on post operative outcome?

Authors:  Anitha Diwakar; Sathya Swaroop Patnaik; Channabasavaraj S Hiremath; Kolli S Chalam; Parvatkumar Dash
Journal:  Ann Card Anaesth       Date:  2019 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.